nach oben

Intensive Care Medicine

Erschienen in:

01.12.2008 | Original

The risk associated with hyperoncotic colloids in patients with shock

verfasst von: Frédérique Schortgen, Emmanuelle Girou, Nicolas Deye, Laurent Brochard, for the CRYCO Study Group

Erschienen in: Intensive Care Medicine | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Crystalloids, artificial and natural colloids have been opposed as representing different strategies for shock resuscitation, but it may be relevant to distinguish fluids based on their oncotic characteristics. This study assessed the risk of renal adverse events in patients with shock resuscitated using hypooncotic colloids, artificial hyperoncotic colloids, hyperoncotic albumin or crystalloids, according to physician’s choice.

Participants and setting

International prospective cohort study including 1,013 ICU patients needing fluid resuscitation for shock. Patients suffering from cirrhosis or receiving plasma were excluded.

Measurements and results

Influence of different types of colloids and crystalloids on the occurrence of renal events (twofold increase in creatinine or need for dialysis) and mortality was assessed using multivariate analyses and propensity score. Statistical adjustment was based on severity at the time of resuscitation, risks factor for renal failure, and on variables influencing physicians’ preferences regarding fluids. A renal event occurred in 17% of patients. After adjustment on potential confounding factors and on propensity score for the use of hyperoncotic colloids, the use of artificial hyperoncotic colloids [OR: 2.48 (1.24–4.97)] and hyperoncotic albumin [OR: 5.99 (2.75–13.08)] was significantly associated with occurrence of renal event. Overall ICU mortality was 27.1%. The use of hyperoncotic albumin was associated with an increased risk of ICU death [OR: 2.79 (1.42–5.47)].

Conclusions

This study suggests that harmful effects on renal function and outcome of hyperoncotic colloids may exist. Although an improper usage of these compounds and confounding factors cannot be ruled out, their use should be regarded with caution, especially because suitable alternatives exist.

Nur mit Berechtigung zugänglich

Schortgen F, Bastugi-Garin S, Deye N, Brochard L (2004) Impact of fluid choice on renal function in critically ill patients with shock. Intensive Care Med 30(suppl 1):S149 (abstract)

Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G (2004) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev:CD000567

Schortgen F, Deye N, Brochard L (2004) Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 30:2222–2229PubMedCrossRef

American Thoracic Society (2004) Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 170:1247–1259CrossRef

Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153PubMed

Ragaller MJ, Theilen H, Koch T (2001) Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12(Suppl 17):S33–S39PubMed

Druml W (2004) Acute renal failure is not a “cute” renal failure!. Intensive Care Med 30:1886–1890PubMedCrossRef

Boer WH, Koomans HA, Dorhout Mees EJ (1987) Renal haemodynamics and sodium handling after hyperoncotic albumin infusion in sodium-restricted normal man. Eur J Clin Invest 17:442–447PubMedCrossRef

Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622PubMedCrossRef

10.

Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916PubMedCrossRef

11.

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, e Network S (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRef

12.

Winkelmayer WC, Glynn RJ, Levin R, Avorn J (2003) Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64:1046–1049PubMedCrossRef

13.

Druml W, Polzleitner D, Laggner AN, Lenz K, Ulrich W (1988) Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 318:252–254

14.

Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C (2003) Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 29:763–769PubMed

15.

Dehne MG, Muhling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G (2001) Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth 13:103–111PubMedCrossRef

16.

Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S (1999) The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 89:1124–1130PubMedCrossRef

17.

Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R (2003) Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96:1453–1459PubMedCrossRef

18.

Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P (2004) 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth 51:236–241PubMed

19.

Rudolf J (2002) Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 14:33–41PubMedCrossRef

20.

The SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256CrossRef

21.

Wunsch H, Linde-Zwirble WT, Angus DC (2006) Methods to adjust for bias and confounding in critical care health services research involving observational data. J Crit Care 21:1–7PubMedCrossRef

22.

(1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874

23.

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American–European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824PubMed

24.

MacCabe W, Jackson G (1962) Gram negative bacteremia, etiology and ecology. Arch Intern Med 110:847–855

25.

Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedCrossRef

26.

Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:802–810PubMedCrossRef

27.

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef

28.

Boldt J, Suttner S (2005) Plasma substitutes. Minerva Anestesiol 71:741–758PubMed

29.

Lamke LO, Liljedahl SO (1976) Plasma volume changes after infusion of various plasma expanders. Resuscitation 5:93–102PubMedCrossRef

30.

Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D (1983) Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11:839–850PubMedCrossRef

31.

Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379PubMedCrossRef

32.

Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516–524CrossRef

33.

Hunter D (2006) First, gather the data. N Engl J Med 354:329–331PubMedCrossRef

34.

Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365PubMedCrossRef

35.

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212PubMedCrossRef

36.

Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, Baud F, Boyer A, Brochard L, Teboul JL (2003) Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 290:2713–2720PubMedCrossRef

37.

Miletin MS, Stewart TE, Norton PG (2002) Influences on physicians’ choices of intravenous colloids. Intensive Care Med 28:917–924PubMedCrossRef

38.

Cowley AW Jr, Skelton MM (1991) Dominance of colloid osmotic pressure in renal excretion after isotonic volume expansion. Am J Physiol 261:H1214–H1225PubMed

39.

Fleming SJ, Dallemagne CR, Endre ZH, Yesberg NE, Cross RB (1992) Acute lowering of plasma oncotic pressure increases filtration fraction and sodium excretion in conscious sheep. Ren Physiol Biochem 15:334–340PubMedCrossRef

40.

Schupbach P, Pappova E, Schilt W, Kollar J, Kollar M, Sipos P, Vucic D (1978) Perfusate oncotic pressure during cardiopulmonary bypass. Optimum level as determined by metabolic acidosis, tissue edema, and renal function. Vox Sang 35:332–344PubMed

41.

Bartels C, Hadzik B, Abel M, Roth B (1996) Renal failure associated with unrecognized hyperoncotic states after pediatric heart surgery. Intensive Care Med 22:492–494PubMedCrossRef

42.

Himpe D, Van Cauwelaert P, Neels H, Stinkens D, Van den Fonteyne F, Theunissen W, Muylaert P, Hermans C, Goossens G, Moeskops J et al (1991) Priming solutions for cardiopulmonary bypass: comparison of three colloids. J Cardiothorac Vasc Anesth 5:457–466PubMedCrossRef

43.

Gore DC, Dalton JM, Gehr TW (1996) Colloid infusions reduce glomerular filtration in resuscitated burn victims. J Trauma 40:356–360PubMedCrossRef

44.

James MF, Latoo MY, Mythen MG, Mutch M, Michaelis C, Roche AM, Burdett E (2004) Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia 59:738–742PubMedCrossRef

45.

Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ (2003) Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 91:196–202PubMedCrossRef

46.

Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A (2007) Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 35:2740–2746PubMed

47.

Mahmood A, Gosling P, Vohra R (2007) Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 94:427–443PubMedCrossRef

48.

Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent JL (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34:2536–2540PubMedCrossRef

49.

Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33:1681–1687PubMedCrossRef

50.

Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98:216–224PubMedCrossRef

51.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409PubMedCrossRef

52.

Moore FA, McKinley BA, Moore EE (2004) The next generation in shock resuscitation. Lancet 363:1988–1996PubMedCrossRef

Titel: The risk associated with hyperoncotic colloids in patients with shock
verfasst von: Frédérique Schortgen
Emmanuelle Girou
Nicolas Deye
Laurent Brochard
for the CRYCO Study Group
Publikationsdatum: 01.12.2008
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 12/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-008-1225-2

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

The risk associated with hyperoncotic colloids in patients with shock

Abstract

Objective

Participants and setting

Measurements and results

Conclusions

Neu im Fachgebiet AINS

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Update AINS

Springer Medizin

Abstract

Objective

Participants and setting

Measurements and results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2008

Liberalization of visiting policies in the ICU: it is also a matter of good information

A comparison of epinephrine and norepinephrine in critically ill patients

Benefits of early tracheotomy: underpowered or overestimated?

Successful extubation of an “unweanable” patient with severe ankylosing spondylitis (Bechterew's disease) using a pumpless extracorporeal lung assist

Room air dilution of heliox given by facemask

Improvement of comfort could be obtained using an early tracheotomy without over-sedation of mechanically ventilated patients: reply to the letter by Veelo et al.

Neu im Fachgebiet AINS

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Update AINS